L. Verdecchia

Women and lung cancer: clinical and molecular profiling as a determinate for treatment decisions: a literature review.

P. Mazzanti, R. Berardi, S. Cascinu, 2009, Critical reviews in oncology/hematology.

Elderly Patients with Advanced Colorectal Cancer: Tolerability and Activity of Chemotherapy

R. Berardi, Rosa R. Silva, D. Mari, 2005, Tumori.

Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients

V. Catalano, R. Berardi, S. Cascinu, 2006, British Journal of Cancer.

COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin

R. Berardi, S. Cascinu, Rosa R. Silva, 2007, American journal of clinical oncology.

New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.

R. Berardi, S. Cascinu, M. Scartozzi, 2005, JOP : Journal of the pancreas.

Chemotherapy for advanced gastric cancer: across the years for a standard of care

R. Berardi, S. Cascinu, E. Galizia, 2007, Expert opinion on pharmacotherapy.

New target therapies in advanced pancreatic cancer.

R. Berardi, S. Cascinu, M. Scartozzi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.

A. Giovagnoni, S. Gasparini, L. Zuccatosta, 2005, Lung cancer.